A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
Autor: | Awada, A. *, Bondarenko, I.N., Bonneterre, J., Nowara, E., Ferrero, J.M., Bakshi, A.V., Wilke, C., Piccart, M. |
---|---|
Zdroj: | In Annals of Oncology April 2014 25(4):824-831 |
Databáze: | ScienceDirect |
Externí odkaz: |